The threat of a double-dip recession may cause some equity investors to look elsewhere – say, Las Vegas – to make up their portfolio shortfalls. If board members desire casino-style thrills, however, upcoming annual meetings should suffice. The 2011 proxy season looks to be a high-stakes craps game thanks to the new rules now tumbling out of the Dodd-Frank Wall Street Reform and Consumer Protection Act. From mandatory say-on-pay to the now-delayed debut of proxy access, the upcoming season promises major changes and new challenges for board members and C-suite executives.
Foley Partner Steven R. Barth will moderate as ISS Special Counsel Patrick McGurn rolls through his take on seven big trends that will rock the 2011 annual meeting scene.
People
Related Insights
24 July 2025
Events
ACI's Inaugural Summit on GLP-1 Law & Policy
Foley partner Kyle Faget, co-chair of the firm’s Medical Devices Area of Focus, is speaking in American Conference Institute’s Inaugural Summit on GLP-1 Law & Policy on July 24.
23 April 2025
Tariff & International Trade Resource
What Every Multinational Company Should Know About…Tariff Strategies for Sell-Side Contracts
With the size and scope of President Trump’s tariffs continuing to shift, this is a critical time for businesses to assess their contracts and determine how increased tariff costs might adversely affect profitability, and whether there are any strategies to mitigate the losses.
22 April 2025
Health Care Law Today
Health Care Marketing: The Seventh Circuit Addresses “Referrals” Under The Anti-Kickback Statute
The case, United States v. Sorenson, addressed whether a Medicare-registered distributor violated the AKS in making payments to advertising, marketing, and manufacturing companies that worked to sell orthopedic braces to Medicare patients. The court held that such payments were not “referrals” within the meaning of the AKS because the payments were made to entities that were neither physicians in a position to refer their patients nor other decisionmakers in positions to “leverage fluid, informal power and influence” over health care decisions.